Clinical trial

Study With Two Capsaicin Topic Treatments in Diabetic Neuropathy.

NCT05029297

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-11-04

PhasePHASE3

Study timeline

Study start (actual)2010-11-04Date precision: day

Registry last updated2021-09-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Neuropathy, Painfulunresolved

Interventions

CapsaicinDRUG · verified · RxNorm: capsaicin

Sponsors & collaborators

Arafarma Group, S.A.lead sponsor

Fundación Teófilo Hernando, Spaincollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05029297 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.